5-Aminotetrazole, 97.0%, 5g

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

N-Benzylguanidinium acetate, 95.0%, 1g

2-((2,5-Dimethoxyphenyl)amino)ethan-1-ol, 97%, 250mg

Pentaerythritol Tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]>95.0%(HPLC)500g

3-Amino-2-methoxybenzoic Acid>98.0%(T)1g

(1R,2R)-2-Aminocyclohexanol hydrochloride, 95.0%, 100g

(4-Sulfamoyl-phenoxy)-acetic acid, 250mg

(4-Bromo-2-nitrophenyl)hydrazine, 96.0%, 1g

1-(4-(Trifluoromethyl)phenyl)cyclopropanamine, 95.0%, 100mg

tert-Butyl 3-Benzyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate>95.0%(GC)(T)250mg

Glass syringe with Luer connection (glass), 2 ml, 1 piece

(R)-3-Hydroxymethyl-piperidine hydrochloride, 95.0%, 10g